Cited by 124Diabetes Treatment and ManagementDiabetes Management and ResearchPharmaceutical Practices and Patient Outcomes

Simplification of insulin regimen in older adults and risk of hypoglycemia

Open access
Munshi, Medha N., Slyne, Christine, Segal, Alissa R., Saul, Nora, Lyons, Courtney, Weinger, Katie·2016·JAMA Internal Medicine

Abstract

This case series describes HbA1c levels and frequency of hypoglycemia among older patients with type 2 diabetes whose treatment regimen was simplified to once-a-day glargine with or without noninsulin agents.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2016.2288

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple trials have shown that deintensification of diabetes treatment can be achieved successfully and safely.

    “Multiple trials have shown that deintensification of diabetes treatment can be achieved successfully and safely (66)(67)(68)(69).”

    From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [66]

    The Methods and Results describe one single-arm study in older adults with type 2 diabetes: insulin-regimen simplification reduced hypoglycemia without worsening overall HbA1c. That supports this citation as an example of successful deintensification, but the paper alone does not establish the broader claim about multiple trials or diabetes treatment generally. The accompanying commentary also calls the evidence preliminary because the study was small and had no concurrent control group. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Simplification of the insulin plan to match an individual's self-management abilities and available social and medical support reduces hypoglycemia and disease-related distress without worsening glycemic outcomes.

    “Simplification of the insulin plan to match an individual's self-management abilities and their available social and medical support in these situations has been shown to reduce hypoglycemia and diseaserelated distress without worsening glycemic outcomes (100-103).”

    From 13. Older Adults: <i>Standards of Care in Diabetes—2024</i> (2024) · cites this paper as [102]

    The Results (page unavailable) report less hypoglycemia and diabetes-related distress after simplification, with no overall change in HbA1c, in 65 older adults with type 2 diabetes. The Methods describe an insulin-switching algorithm, but do not say the plan was tailored to each person's self-management abilities or available social and medical support. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Simplification of the insulin plan to match an individual's self-management abilities and their available social and medical support reduces hypoglycemia and disease-related distress without worsening glycemic outcomes.

    “Simplification of the insulin plan to match an individual's self-management abilities and their available social and medical support in these situations has been shown to reduce hypoglycemia and disease-related distress without worsening glycemic outcomes (107-110).”

    From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [109]

    The Results report less hypoglycemia and diabetes-related distress after simplification, with no overall change in HbA1c, among 65 older adults with type 2 diabetes (page not provided). The Methods describe a regimen-switching algorithm, but do not say it was tailored to each person’s self-management abilities or available social and medical support. The study was also single-arm, so its findings are less definitive than the phrase “has been shown” may imply. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Simplification of the insulin plan to match an individual's self-management abilities and available social and medical support is associated with reduced hypoglycemia and disease-related distress without worsening glycemic outcomes.

    “Studies suggest that simplification of the insulin plan to match an individual’s self-management abilities and their available social and medical support is associated with reduced hypoglycemia and disease-related distress without worsening glycemic outcomes”

    From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [151]

    The Conclusions and Results report reduced hypoglycemia and diabetes-related distress without an overall worsening of glycemic control after insulin-regimen simplification in older adults. The paper does not establish that the regimen was tailored to each person’s self-management abilities or available social and medical support; its Methods describe a simplification algorithm instead. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 6 · Cited by 124

Authors
Munshi, M. N., Slyne, C., Segal, A. R., Saul, N., Lyons, C., & Weinger, K.
Affiliations
Joslin Diabetes Center (US)
Corresponding author
Munshi, Medha N.
Venue
JAMA Internal Medicine
Published
2016-07-01
Volume
176
Issue
7
Pages
1023
ISSN
2168-6106 (ISSN-L)
OpenAlex
W2411033625
Cited by
124
References
6
Citations by year
2026: 4 · 2025: 13 · 2024: 15 · 2023: 13 · 2022: 11 · 2021: 10 · 2020: 18 · 2019: 15 · 2018: 12 · 2017: 10 · 2016: 3
FWCI
13.38
Type
journal article
Language
en
Open access
Locations
  • JAMA Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Robert Wood Johnson Foundation
  • Eli Lilly and Company
  • Sanofi
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
hypoglycemia, type 2 diabetes, older adults, glargine, basal insulin, HbA1c, glycemic control
MeSH terms
Insulin Glargine, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Blood Glucose Self-Monitoring, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review